Sandoz comments on Tilray

Sandoz Canada’s proposed entry into the medical cannabis space through its recent strategic alliance agreement with local producer Tilray broadly “complements its portfolio”, and “demonstrates again that the patient is at the heart of our work”, the Novartis affiliate has told Generics bulletin.

More from Archive

More from Generics Bulletin